Strata Skin Sciences, Inc. - Common Stock (SSKN)
1.7900
-0.0300 (-1.65%)
NASDAQ · Last Trade: Aug 18th, 5:53 PM EDT
Detailed Quote
Previous Close | 1.820 |
---|---|
Open | 1.810 |
Bid | 1.510 |
Ask | 1.910 |
Day's Range | 1.720 - 1.856 |
52 Week Range | 1.780 - 3.790 |
Volume | 26,736 |
Market Cap | 62.15M |
PE Ratio (TTM) | -0.6303 |
EPS (TTM) | -2.8 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 42,068 |
Chart
About Strata Skin Sciences, Inc. - Common Stock (SSKN)
Strata Skin Sciences is a medical technology company dedicated to the development and commercialization of innovative solutions for the treatment of various skin conditions, particularly focused on dermatological therapies and aesthetic treatments. The company utilizes advanced technologies to create products that enhance the effectiveness of dermatological treatments, aiming to improve patient outcomes and satisfaction. Through its research and development efforts, Strata Skin Sciences is committed to addressing unmet medical needs in skincare and providing healthcare professionals with effective tools for managing skin diseases and aesthetic concerns. Read More
News & Press Releases
Via Benzinga · July 22, 2025

Via Benzinga · December 20, 2024

RALEIGH, NC / ACCESSWIRE / September 20, 2024 / iAccess Alpha's "Buyside Best Ideas Virtual Fall Conference" is taking place on September 24-25, 2024.
Via ACCESSWIRE · September 20, 2024

SSKN stock results show that Strata Skin Sciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

SSKN stock results show that Strata Skin Sciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2023.
Via InvestorPlace · June 10, 2024

Via Benzinga · May 16, 2024

SSKN stock results show that Strata Skin Sciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · May 15, 2024

Via Benzinga · April 29, 2024

SSKN stock results show that Strata Skin Sciences missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 27, 2024

Via Benzinga · March 27, 2024

Via Benzinga · March 27, 2024